The Valley Desk

NCT05285891 · Interventional trial

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Overall registry status Active not recruiting

Phase 4

Conditions Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov